- Home
- ICCC vs EEA Comparison
ICCC vs EEA Comparison
Compare ICCC & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- EEA
- Stock Information
- Founded
- ICCC 1982
- EEA 1986
- Country
- ICCC United States
- EEA Germany
- Employees
- ICCC N/A
- EEA N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- EEA Trusts Except Educational Religious and Charitable
- Sector
- ICCC Health Care
- EEA Finance
- Exchange
- ICCC Nasdaq
- EEA Nasdaq
- Market Cap
- ICCC 48.3M
- EEA 57.7M
- IPO Year
- ICCC 1987
- EEA N/A
- Fundamental
- Price
- ICCC $5.50
- EEA $9.06
- Analyst Decision
- ICCC
- EEA
- Analyst Count
- ICCC 0
- EEA 0
- Target Price
- ICCC N/A
- EEA N/A
- AVG Volume (30 Days)
- ICCC 39.3K
- EEA 9.2K
- Earning Date
- ICCC 05-14-2025
- EEA 01-01-0001
- Dividend Yield
- ICCC N/A
- EEA 1.92%
- EPS Growth
- ICCC N/A
- EEA N/A
- EPS
- ICCC N/A
- EEA N/A
- Revenue
- ICCC $26,493,169.00
- EEA N/A
- Revenue This Year
- ICCC N/A
- EEA N/A
- Revenue Next Year
- ICCC N/A
- EEA N/A
- P/E Ratio
- ICCC N/A
- EEA N/A
- Revenue Growth
- ICCC 51.63
- EEA N/A
- 52 Week Low
- ICCC $3.34
- EEA $7.45
- 52 Week High
- ICCC $5.82
- EEA $9.26
- Technical
- Relative Strength Index (RSI)
- ICCC 59.13
- EEA 54.76
- Support Level
- ICCC $4.63
- EEA $8.11
- Resistance Level
- ICCC $5.72
- EEA $9.28
- Average True Range (ATR)
- ICCC 0.42
- EEA 0.20
- MACD
- ICCC 0.05
- EEA 0.03
- Stochastic Oscillator
- ICCC 79.82
- EEA 89.62
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.